Search results
Results from the WOW.Com Content Network
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal resources as far as possible ...
Voting yes on Prop. 34 is a vote in favor of stricter rules governing certain California nonprofits that participate in the federal 340B program, requiring them to spend at least 98% of their ...
Prescription drug list prices in the United States continually are among the highest in the world. [1] [2] The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015.
Proposition 34, titled Restricts Spending of Prescription Drug Revenues By Certain Health Care Providers, was a California ballot proposition and initiative statute in the 2024 general election on November 5.
Pharmaceutical companies are legally required to pay for a portion of the medications used by critical access hospitals as part of the 340B Drug Pricing Program. Few CAHs provide intensive care treatment. A review of CAHs in the early 2000s counted 26% of the hospitals providing intensive care-level treatment to at least one patient.
The Medicaid Drug Rebate Program is a program in the United States that was created by the Omnibus Budget Reconciliation Act of 1990 (OBRA'90).. The program establishes mandatory rebates that drug manufacturers must pay state Medicaid agencies related to the dispensing of outpatient prescription drugs covered by Medicaid.
Arkansas on Monday sued two pharmacy benefit managers that oversee coverage for insurers, employers and other large clients, accusing them of fueling the opioid crisis in the state. Attorney ...
Ramsell has also built a specialized contract pharmacy network that ensures access and significant savings on HIV/AIDS medications whose average costs per year are between $12,000 to $20,000. [36] These savings allow LA County to manage the expenses associated with HIV medications and increase access to additional medical services not provided ...